Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
CALL
Baker Hughes
BKR
$64.5B
| $974K | ﹤0.01% |
28,800
-14,300
| -33% | -$473K |
|
|
LABL
3602
DELISTED
Multi-Color Corp
LABL
| $974K | ﹤0.01% |
15,658
+6,724
| +75% | +$430K |
|
|
HSKA
3603
DELISTED
Heska Corp
HSKA
| $973K | ﹤0.01% |
8,587
+6,117
| +248% | +$643K |
|
3604
Forrester Research
FORR
$223M
| $972K | ﹤0.01% |
21,175
+14,809
| +233% | +$681K |
|
|
NVRO
3605
PUT
DELISTED
NEVRO CORP.
NVRO
| $969K | ﹤0.01% |
17,000
-8,000
| -32% | -$500K |
|
|
IPHS
3606
DELISTED
Innophos Holdings, Inc.
IPHS
| $969K | ﹤0.01% |
21,825
+13,917
| +176% | +$636K |
|
3607
John B. Sanfilippo & Son
JBSS
$1.01B
| $968K | ﹤0.01% |
13,566
+9,757
| +256% | +$733K |
|
|
ASNA
3608
CALL
DELISTED
Ascena Retail Group, Inc.
ASNA
| $968K | ﹤0.01% |
10,590
+1,030
| +11% | +$85.3K |
|
|
TSS
3609
CALL
DELISTED
Total System Services, Inc.
TSS
| $968K | ﹤0.01% |
9,800
-1,500
| -13% | -$141K |
|
|
JCP
3610
DELISTED
J.C. Penney Company, Inc.
JCP
| $967K | ﹤0.01% |
583,377
+318,689
| +120% | +$676K |
|
|
GOLD
3611
PUT
DELISTED
Randgold Resources Ltd
GOLD
| $967K | ﹤0.01% |
13,700
-9,500
| -41% | -$653K |
|
3612
PUT
GDS Holdings
GDS
$6.91B
| $966K | ﹤0.01% |
+27,500
| New | +$989K |
|
3613
Herc Holdings
HRI
$5.72B
| $963K | ﹤0.01% |
18,808
+15,598
| +486% | +$844K |
|
|
NAV
3614
PUT
DELISTED
Navistar International
NAV
| $963K | ﹤0.01% |
25,000
-8,600
| -26% | -$359K |
|
|
SRCL
3615
CALL
DELISTED
Stericycle Inc
SRCL
| $962K | ﹤0.01% |
16,400
-3,900
| -19% | -$249K |
|
3616
PUT
Urban Outfitters
URBN
$6.66B
| $961K | ﹤0.01% |
23,500
-5,900
| -20% | -$265K |
|
|
JOBS
3617
DELISTED
51job Inc
JOBS
| $961K | ﹤0.01% |
12,476
-2,431
| -16% | -$194K |
|
|
CTRL
3618
DELISTED
Control4 Corporation
CTRL
| $961K | ﹤0.01% |
27,994
+6,854
| +32% | +$211K |
|
|
HIBB
3619
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $961K | ﹤0.01% |
51,017
-71,766
| -58% | -$1.63M |
|
3620
CALL
Vanguard Real Estate ETF
VNQ
$39.2B
| $960K | ﹤0.01% |
11,900
-4,100
| -26% | -$338K |
|
3621
CALL
Ally Financial
ALLY
$13.7B
| $957K | ﹤0.01% |
36,200
-500
| -1% | -$13.6K |
|
|
3622
CALL
Urban Outfitters
URBN
$6.66B
| $957K | ﹤0.01% |
23,400
-2,600
| -10% | -$117K |
|
3623
Adeia
ADEA
$3.29B
| $954K | ﹤0.01% |
242,593
+154,587
| +176% | +$658K |
|
|
TIF
3624
CALL
DELISTED
Tiffany & Co.
TIF
| $954K | ﹤0.01% |
7,400
-7,300
| -50% | -$954K |
|
3625
Amneal Pharmaceuticals
AMRX
$6.15B
| $953K | ﹤0.01% |
42,951
-325,205
| -88% | -$6.84M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.